Search Results 301-310 of 17804 for Coagulate

1. IFX_HU2.0 As An Adjunctive Therapy To Pembrolixumab In Checkpoint Inhibitor Naive Subjects With Advanced Or Metastatic Merkel Cell Carcinoma - Mayo Clinic

   Blood Coagulation Parameters: PT, INR < 1.5 x institutional ULN unless subject is therapeutically anticoagulated. If on anticoagulation PT/INR need to be ...

2. A Clinical Study To Test If An Investigational Treatment Called BNT326 Is Safe And Potentially Beneficial When Used Alone Or In Combination With Other Investigational Treatments Such As BNT327, For People With Advanced Malignant Tumors - Mayo Clinic

   Participants with significant risks of hemorrhage or evidence of major coagulation disorders as specified in the protocol. Cohort 1E: Have histological ...

3. A Study of SGT-501 Gene Therapy in Catecholaminergic Polymorphic Ventricular Tachycardia - Mayo Clinic

   Clinically significant abnormalities of coagulation including international normalized ratio or activated partial thromboplastin time > 1.2 × ULN or platelets < ...

4. A Study of Biomarker-Directed, Pembrolizumab (MK-3475) Based Combination Therapy for Advanced Non-Small Cell Lung Cancer (MK-3475-495) - Mayo Clinic

   Coagulation. International normalized ratio (INR) OR prothrombin time (PT);; Activated partial thromboplastin time (aPTT) ≤.5 × ULN unless participant is ...

5. A Study of CC-90002 in Subjects With Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS) - Mayo Clinic

   Eligible study subjects must exhibit acceptable liver, renal, and coagulation function as assessed by laboratory tests. Females and males must practice true ...

6. A Study to Detect Minimally-Invasive Barrett's Esophagus and Barrett's Esophagus Related Dysplasia/Carcinoma - Mayo Clinic

   Patients with prior history of ablation (photodynamic therapy, radiofrequency ablation, cryotherapy, argon plasma coagulation). Patients with history of ...

7. Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke 3 - Mayo Clinic

   Known hereditary or acquired hemorrhagic diathesis, coagulation factor deficiency; recent oral anticoagulant therapy with INR > 3 (recent use of one of the ...

8. Publications - Juan C. Diaz Soto, M.D. - Mayo Clinic

   Coagulation profile of human COVID-19 convalescent plasma. Sci Rep. 2022 Jan 12; 12 (1):637. View PubMed; Senefeld JW, Johnson PW, Kunze KL, Bloch EM, van ...

9. AXIOS Lumen Apposing Metal Stent for Walled Off Necrosis Drainage IDE Study - Mayo Clinic

   Abnormal coagulation: INR > 1.5 and not correctable;; Presence of a bleeding disorder;; Platelets < 50,000/mm3. Intervening gastric varices or unavoidable ...

10. Colic - Symptoms and causes - Mayo Clinic

    Consoling a baby who cries a lot for no apparent reason is a challenge. Learn strategies for caring for your infant and coping with the stress.